Fresno Cardiovascular Disease

Topics

• Cardiac Imaging and Diagnostics 78
• Heart Failure Treatment and Management 77
• Lipoproteins and Cardiovascular Health 68
• Coronary Interventions and Diagnostics 58
• Atrial Fibrillation Management and Outcomes 52
• Acute Myocardial Infarction Research 45
• Cardiac Valve Diseases and Treatments 41
• Blood Pressure and Hypertension Studies 36
• Diabetes, Cardiovascular Risks, and Lipoproteins 26
• Cardiac pacing and defibrillation studies 24
• Diabetes Treatment and Management 24
• Cardiovascular Function and Risk Factors 20

Most cited

1. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.

   Circulation · 2022 · 519 citations · Prakash Deedwania, Tushar Acharya

2. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.

   Circulation · 2023 · 108 citations · Prakash Deedwania

3. Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction.

   Drugs · 2023 · 64 citations · Prakash Deedwania

4. Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.

   Circulation · 2021 · 88 citations · Prakash Deedwania

5. Why Do Patients Leave against Medical Advice? Reasons, Consequences, Prevention, and Interventions.

   Healthcare (Basel, Switzerland) · 2021 · 64 citations · Asseel Al-Bayati

6. Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

   Journal of clinical lipidology · 2024 · 33 citations · Prakash Deedwania

7. Oral magnesium and outcomes in US veterans with heart failure.

   European heart journal · 2026 · 6 citations · Prakash Deedwania

8. Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial.

   JAMA cardiology · 2021 · 64 citations · Prakash Deedwania